These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23927860)

  • 1. Bath salt abuse: more than just hot water.
    Terry SM
    J Emerg Nurs; 2014 Jan; 40(1):88-91. PubMed ID: 23927860
    [No Abstract]   [Full Text] [Related]  

  • 2. How to recognize a patient who's high on "bath salts".
    Penders TM
    J Fam Pract; 2012 Apr; 61(4):210-2. PubMed ID: 22482104
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral pharmacology of designer cathinones: a review of the preclinical literature.
    Gregg RA; Rawls SM
    Life Sci; 2014 Feb; 97(1):27-30. PubMed ID: 24231450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic legal intoxicating drugs: the emerging 'incense' and 'bath salt' phenomenon.
    Jerry J; Collins G; Streem D
    Cleve Clin J Med; 2012 Apr; 79(4):258-64. PubMed ID: 22473725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.
    Cameron KN; Kolanos R; Solis E; Glennon RA; De Felice LJ
    Br J Pharmacol; 2013 Apr; 168(7):1750-7. PubMed ID: 23170765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bath salt abuse: new designer drug keeps EMS crews busy nationwide.
    Nevin J
    JEMS; 2011 Aug; 36(8):58-60. PubMed ID: 21819904
    [No Abstract]   [Full Text] [Related]  

  • 7. Crystallographic investigations of select cathinones: emerging illicit street drugs known as `bath salts'.
    Wood MR; Lalancette RA; Bernal I
    Acta Crystallogr C Struct Chem; 2015 Jan; 71(Pt 1):32-8. PubMed ID: 25567572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are "bath salts" the next generation of stimulant abuse?
    Winder GS; Stern N; Hosanagar A
    J Subst Abuse Treat; 2013 Jan; 44(1):42-5. PubMed ID: 22445773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.
    Cameron K; Kolanos R; Vekariya R; De Felice L; Glennon RA
    Psychopharmacology (Berl); 2013 Jun; 227(3):493-9. PubMed ID: 23371489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants.
    Simmons SJ; Leyrer-Jackson JM; Oliver CF; Hicks C; Muschamp JW; Rawls SM; Olive MF
    ACS Chem Neurosci; 2018 Oct; 9(10):2379-2394. PubMed ID: 29714473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
    Anneken JH; Angoa-Pérez M; Kuhn DM
    J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
    Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
    Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats.
    Huang PK; Aarde SM; Angrish D; Houseknecht KL; Dickerson TJ; Taffe MA
    Drug Alcohol Depend; 2012 Nov; 126(1-2):168-75. PubMed ID: 22664136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems.
    Luethi D; Kolaczynska KE; Walter M; Suzuki M; Rice KC; Blough BE; Hoener MC; Baumann MH; Liechti ME
    J Psychopharmacol; 2019 Jul; 33(7):831-841. PubMed ID: 31038382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reinforcing Effects of Cathinone NPS in the Intravenous Drug Self-Administration Paradigm.
    Watterson LR; Olive MF
    Curr Top Behav Neurosci; 2017; 32():133-143. PubMed ID: 27431398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment.
    Kiyatkin EA; Ren SE
    Curr Top Behav Neurosci; 2017; 32():183-207. PubMed ID: 27677782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bath salts: they are not what you think.
    Wieland DM; Halter MJ; Levine C
    J Psychosoc Nurs Ment Health Serv; 2012 Feb; 50(2):17-21. PubMed ID: 22439144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online.
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jan; 208(1):12-5. PubMed ID: 22008731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Bath salts" and "plant food" products: the experience of one regional US poison center.
    Murphy CM; Dulaney AR; Beuhler MC; Kacinko S
    J Med Toxicol; 2013 Mar; 9(1):42-8. PubMed ID: 22733603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters.
    Magee CP; German CL; Siripathane YH; Curtis PS; Anderson DJ; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2020 Aug; 374(2):273-282. PubMed ID: 32385092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.